FDA guidance on off-label promotion and the state of the literature from sponsors

被引:21
作者
Psaty, Bruce M. [1 ,2 ,3 ,4 ]
Ray, Wayne [5 ,6 ]
机构
[1] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[2] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[3] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA
[4] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[5] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Educ & Res Therapeut, Nashville, TN 37212 USA
[6] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37203 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 299卷 / 16期
关键词
D O I
10.1001/jama.299.16.1949
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1949 / 1951
页数:3
相关论文
共 14 条
[1]   Effects of conjugated, equine estrogen in postmenopausal women with hysterectomy - The women's health initiative randomized controlled trial [J].
Anderson, GL ;
Limacher, M ;
Assaf, AR ;
Bassford, T ;
Beresford, SAA ;
Black, H ;
Bonds, D ;
Brunner, R ;
Brzyski, R ;
Caan, B ;
Chlebowski, R ;
Curb, D ;
Gass, M ;
Hays, J ;
Heiss, G ;
Hendrix, S ;
Howard, BV ;
Hsia, J ;
Hubbell, A ;
Jackson, R ;
Johnson, KC ;
Judd, H ;
Kotchen, JM ;
Kuller, L ;
LaCroix, AZ ;
Lane, D ;
Langer, RD ;
Lasser, N ;
Lewis, CE ;
Manson, J ;
Margolis, K ;
Ockene, J ;
O'Sullivan, MJ ;
Phillips, L ;
Prentice, RL ;
Ritenbaugh, C ;
Robbins, J ;
Rossouw, JE ;
Sarto, G ;
Stefanick, ML ;
Van Horn, L ;
Wactawski-Wende, J ;
Wallace, R ;
Wassertheil-Smoller, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1701-1712
[2]  
Blackwell AE, 2003, FOOD DRUG LAW J, V58, P439
[3]   Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8 [J].
Curfman, GD ;
Morrissey, S ;
Drazen, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26) :2813-2814
[4]   Ghost authorship in industry-initiated randomised trials [J].
Gotzsche, Peter C. ;
Hrobjartsson, Asbjorn ;
Johansen, Helle Krogh ;
Haahr, Mette T. ;
Altman, Douglas G. ;
Chan, An-Wen .
PLOS MEDICINE, 2007, 4 (01) :47-52
[5]   High-dose statins in acute coronary syndromes - Not just lipid levels [J].
Nissen, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (11) :1365-1367
[6]   Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment - A case study based on documents from rofecoxib litigation [J].
Psaty, Bruce M. ;
Kronmal, Richard A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (15) :1813-1817
[7]   Off label use: a mistake or a need? [J].
REVISTA DE SAUDE PUBLICA, 2012, 46 (02) :398-399
[8]   Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].
Rossouw, JE ;
Anderson, GL ;
Prentice, RL ;
LaCroix, AZ ;
Kooperberg, C ;
Stefanick, ML ;
Jackson, RD ;
Beresford, SAA ;
Howard, BV ;
Johnson, KC ;
Kotchen, JM ;
Ockene, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333
[9]   Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry? [J].
Sismondo, Sergio .
PLOS MEDICINE, 2007, 4 (09) :1429-1433
[10]   Medical journals are an extension of the marketing arm of pharmaceutical companies [J].
Smith, R .
PLOS MEDICINE, 2005, 2 (05) :364-366